I agree that this site is using cookies. You can find further informations here.
X
Monge-Escartín, Inés
20  results:
Search for persons X
?
1

Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics a..:

Marco, Daniel N. ; Molina, Mònica ; Guio, Ana-María...
Pharmaceuticals.  17 (2024)  5 - p. 553 , 2024
Link: https://doi.org/10.3390/..
 
?
2

At-Home Foscarnet Administration in Patients with Cytomegal..:

Ruiz-Boy, Sonia ; Pedraza, Alexandra ; Prat, Marta...
Pharmaceuticals.  16 (2023)  12 - p. 1741 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Real-world data of the use and experience of caplacizumab f..:

Albanell-Fernández, Marta ; Monge-Escartín, Inés ; Carcelero-San Martín, Esther...
Transfusion and Apheresis Science.  62 (2023)  3 - p. 103722 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Assessment of the change of antiemetic prophylaxis from dou..:

Albanell-Fernández, Marta ; Pérez Sánchez, Ángela ; Monge-Escartín, Inés...
Journal of Oncology Pharmacy Practice.  , 2023
Link: https://doi.org/10.1177/..
 
?
5

Caplacizumab in acquired thrombotic thrombocytopenic thromb..:

Albanell-Fernández, Marta ; Monge-Escartín, Inés ; Cid, Joan
Medicina Clínica (English Edition).  161 (2023)  6 - p. 267-268 , 2023
Link: https://doi.org/10.1016/..
 
?
6

ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtan..:

Griguolo, Gaia ; Brasó-Maristany, Fara ; González-Farré, Blanca...
Cancers.  12 (2020)  7 - p. 1902 , 2020
Link: https://doi.org/10.3390/..
 
?
7

SAT-231-Impact of the HCV cure with DAAs in the use of conc..:

González-Colominas, Elena ; Batlle, Marc ; Monge-Escartín, Inés...
Journal of Hepatology.  70 (2019)  1 - p. e732 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Impact of sustained virological response in the use of conc..:

González-Colominas, E. ; Batlle, M. ; Monge-Escartín, Inés...
Journal of Hepatology.  68 (2018)  - p. S547 , 2018
Link: https://doi.org/10.1016/..
 
?
9

¿Conlleva la desprescripción de condroprotectores en pacien..:

Barraquer Comes, Anna ; Monge Escartín, Inés ; Álvarez Carrera, Asunción..
Pharmaceutical Care España.  24 (2022)  1 - p. 7-19 , 2022
Link: https://doi.org/10.60103..
 
?
10

ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtan..:

Griguolo, Gaia ; Brasó-Maristany, Fara ; González-Farré, Blanca...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409149/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
11

At-Home Foscarnet Administration in Patients with Cytomegal..:

Sonia Ruiz-Boy ; Alexandra Pedraza ; Marta Prat...
https://www.mdpi.com/1424-8247/16/12/1741.  , 2023
Link: https://doi.org/10.3390/..
 
?
12

¿Conlleva la desprescripción de condroprotectores en pacien..:

Anna Barraquer Comes ; Inés Monge Escartín ; Asunción Álvarez Carrera..
https://pharmcareesp.com/index.php/PharmaCARE/article/view/665.  , 2022
Link: https://doaj.org/article..
 
?
13

¿Conlleva la desprescripción de condroprotectores en pacien..:

Anna Barraquer Comes ; Inés Monge Escartín ; Asunción Álvarez Carrera..
https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/665.  , 2022
Link: https://doaj.org/article..
 
?
14

ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtan..:

Gaia Griguolo ; Fara Brasó-Maristany ; Blanca González-Farré...
Methods and Technologies Development.  , 2020
Link: https://doi.org/10.3390/..
 
?
15

ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtan..:

Gaia Griguolo ; Fara Brasó-Maristany ; Blanca González-Farré...
https://www.mdpi.com/2072-6694/12/7/1902.  , 2020
Link: https://doi.org/10.3390/..
 
1-15